{
    "2021-06-01": [
        [
            {
                "time": "",
                "original_text": "百诚医药：业务规模小且集中，需关注仿制药一致性评价业务放缓风险",
                "features": {
                    "keywords": [
                        "百诚医药",
                        "业务规模",
                        "仿制药",
                        "一致性评价",
                        "风险"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业：中金医药月度10+7组合：2021年6月组合",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "中金医药",
                        "月度组合",
                        "2021年6月"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物月报：“三胎”“七普”相继发布 医药空间广阔 继续把握赛道布局、大小兼备的思路",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三胎",
                        "七普",
                        "医药空间",
                        "赛道布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "JP Morgan Chase & Co.增持康龙化成股份约32.13万股",
                "features": {
                    "keywords": [
                        "JP Morgan Chase",
                        "康龙化成",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成现2笔大宗交易 共成交5,552.70万元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业月报：国内疫情防控新阶段 跟进检测需求和疫苗接种情况",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "疫情防控",
                        "检测需求",
                        "疫苗接种"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药龙头普遍回暖走高，通策医疗大涨5%",
                "features": {
                    "keywords": [
                        "医药龙头",
                        "回暖",
                        "通策医疗",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}